| regulation of fatty acid oxidation | GO:0046320 | 10 | 1.000 | |
| cellular response to peptide | GO:1901653 | 92 | 1.000 | |
| cellular lipid catabolic process | GO:0044242 | 52 | 1.000 | |
| neuropeptide signaling pathway | GO:0007218 | 19 | 1.000 | |
| monosaccharide metabolic process | GO:0005996 | 106 | 1.000 | |
| regulation of fatty acid metabolic process | GO:0019217 | 28 | 1.000 | |
| regulation of triglyceride metabolic process | GO:0090207 | 17 | 1.000 | |
| acylglycerol metabolic process | GO:0006639 | 55 | 0.999 | |
| regulation of nitrogen cycle metabolic process | GO:1903314 | 1 | 0.999 | |
| hexose metabolic process | GO:0019318 | 98 | 0.999 | |
| response to growth factor | GO:0070848 | 198 | 0.999 | |
| positive regulation of lipid catabolic process | GO:0050996 | 6 | 0.998 | |
| response to peptide hormone | GO:0043434 | 127 | 0.998 | |
| regulation of carbohydrate biosynthetic process | GO:0043255 | 40 | 0.998 | |
| cellular response to insulin stimulus | GO:0032869 | 78 | 0.998 | |
| response to testosterone | GO:0033574 | 3 | 0.998 | |
| positive regulation of fatty acid oxidation | GO:0046321 | 4 | 0.998 | |
| acylglycerol catabolic process | GO:0046464 | 11 | 0.998 | |
| sequestering of triglyceride | GO:0030730 | 6 | 0.997 | |
| regulation of insulin receptor signaling pathway | GO:0046626 | 21 | 0.996 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.995 | |
| triglyceride metabolic process | GO:0006641 | 51 | 0.995 | |
| cellular carbohydrate metabolic process | GO:0044262 | 119 | 0.995 | |
| negative regulation of lipid catabolic process | GO:0050995 | 6 | 0.995 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.994 | |
| rhythmic process | GO:0048511 | 174 | 0.994 | |
| positive regulation of cyclic nucleotide biosynthetic process | GO:0030804 | 24 | 0.994 | |
| drug metabolic process | GO:0017144 | 4 | 0.994 | |
| neutral lipid metabolic process | GO:0006638 | 57 | 0.994 | |
| regulation of carbohydrate metabolic process | GO:0006109 | 75 | 0.994 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.994 | |
| gland development | GO:0048732 | 330 | 0.993 | |
| apoptotic process involved in mammary gland involution | GO:0060057 | 4 | 0.993 | |
| gluconeogenesis | GO:0006094 | 39 | 0.992 | |
| positive regulation of apoptotic process involved in mammary gland involution | GO:0060058 | 4 | 0.990 | |
| adenylate cyclase activating g protein coupled receptor signaling pathway | GO:0007189 | 30 | 0.990 | |
| positive regulation of nucleotide biosynthetic process | GO:0030810 | 26 | 0.989 | |
| organic acid catabolic process | GO:0016054 | 51 | 0.989 | |
| response to nutrient levels | GO:0031667 | 109 | 0.988 | |
| response to bile acid | GO:1903412 | 1 | 0.988 | |
| lipid catabolic process | GO:0016042 | 69 | 0.987 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.985 | |
| alpha amino acid metabolic process | GO:1901605 | 59 | 0.985 | |
| response to corticosteroid | GO:0031960 | 20 | 0.983 | |
| regulation of glutamine family amino acid metabolic process | GO:0000820 | 1 | 0.981 | |
| response to peptide | GO:1901652 | 136 | 0.981 | |
| glucose metabolic process | GO:0006006 | 92 | 0.981 | |
| fatty acid metabolic process | GO:0006631 | 121 | 0.980 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.977 | |
| regulation of gluconeogenesis | GO:0006111 | 30 | 0.977 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.975 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.972 | |
| negative regulation of lipid metabolic process | GO:0045833 | 30 | 0.970 | |
| negative regulation of peptide hormone secretion | GO:0090278 | 16 | 0.970 | |
| regulation of lipid catabolic process | GO:0050994 | 15 | 0.970 | |
| positive regulation of triglyceride metabolic process | GO:0090208 | 9 | 0.970 | |
| fatty acid beta oxidation | GO:0006635 | 16 | 0.970 | |
| regulation of cellular carbohydrate metabolic process | GO:0010675 | 75 | 0.966 | |
| response to glucocorticoid | GO:0051384 | 20 | 0.964 | |
| negative regulation of gluconeogenesis | GO:0045721 | 9 | 0.964 | |
| small molecule catabolic process | GO:0044282 | 71 | 0.963 | |
| triglyceride catabolic process | GO:0019433 | 9 | 0.961 | |
| regulation of glucose metabolic process | GO:0010906 | 60 | 0.961 | |
| cellular response to peptide hormone stimulus | GO:0071375 | 92 | 0.960 | |
| fatty acid oxidation | GO:0019395 | 28 | 0.960 | |
| regulation of hormone secretion | GO:0046883 | 88 | 0.959 | |
| response to insulin | GO:0032868 | 100 | 0.958 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.958 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.956 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.956 | |
| monocarboxylic acid catabolic process | GO:0072329 | 27 | 0.954 | |
| nitric oxide mediated signal transduction | GO:0007263 | 4 | 0.952 | |
| regulation of peptide secretion | GO:0002791 | 77 | 0.951 | |
| response to alcohol | GO:0097305 | 48 | 0.949 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.948 | |
| digestion | GO:0007586 | 40 | 0.942 | |
| ammonia assimilation cycle | GO:0019676 | 2 | 0.942 | |
| fatty acid catabolic process | GO:0009062 | 25 | 0.940 | |
| cellular response to transforming growth factor beta stimulus | GO:0071560 | 88 | 0.940 | |
| positive regulation of lipid metabolic process | GO:0045834 | 40 | 0.939 | |
| white fat cell differentiation | GO:0050872 | 15 | 0.939 | |
| regulation of feeding behavior | GO:0060259 | 3 | 0.936 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.932 | |
| regulation of glutamate metabolic process | GO:2000211 | 1 | 0.932 | |
| monosaccharide biosynthetic process | GO:0046364 | 44 | 0.931 | |
| brown fat cell differentiation | GO:0050873 | 36 | 0.931 | |
| positive regulation of insulin receptor signaling pathway | GO:0046628 | 4 | 0.928 | |
| glucose homeostasis | GO:0042593 | 128 | 0.927 | |
| connective tissue development | GO:0061448 | 179 | 0.924 | |
| regulation of the force of heart contraction by chemical signal | GO:0003057 | 5 | 0.919 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.919 | |
| regulation of androgen receptor signaling pathway | GO:0060765 | 3 | 0.919 | |
| mammary gland duct morphogenesis | GO:0060603 | 38 | 0.918 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.916 | |
| regulation of urea metabolic process | GO:0034255 | 1 | 0.915 | |
| negative regulation of hormone secretion | GO:0046888 | 20 | 0.909 | |
| regulation of vitamin d biosynthetic process | GO:0060556 | 1 | 0.908 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.907 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.906 | |
| cyclic purine nucleotide metabolic process | GO:0052652 | 43 | 0.905 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.904 | |
| carbohydrate biosynthetic process | GO:0016051 | 74 | 0.898 | |
| creatinine metabolic process | GO:0046449 | 3 | 0.897 | |
| collagen biosynthetic process | GO:0032964 | 7 | 0.897 | |
| neutral lipid catabolic process | GO:0046461 | 11 | 0.897 | |
| response to transforming growth factor beta | GO:0071559 | 88 | 0.896 | |
| positive regulation of lipid storage | GO:0010884 | 10 | 0.893 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.890 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.889 | |
| drug catabolic process | GO:0042737 | 2 | 0.887 | |
| tertiary branching involved in mammary gland duct morphogenesis | GO:0060748 | 3 | 0.886 | |
| multicellular organism growth | GO:0035264 | 161 | 0.886 | |
| glutamine family amino acid metabolic process | GO:0009064 | 15 | 0.885 | |
| glutamate metabolic process | GO:0006536 | 9 | 0.885 | |
| negative regulation of androgen receptor signaling pathway | GO:0060766 | 3 | 0.884 | |
| succinate metabolic process | GO:0006105 | 4 | 0.877 | |
| g protein coupled receptor internalization | GO:0002031 | 3 | 0.875 | |
| regulation of chromatin modification | GO:1903308 | 57 | 0.875 | |
| regulation of ammonia assimilation cycle | GO:2001248 | 1 | 0.869 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.867 | |
| circadian rhythm | GO:0007623 | 114 | 0.867 | |
| steroid metabolic process | GO:0008202 | 119 | 0.865 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.865 | |
| regulation of camp metabolic process | GO:0030814 | 30 | 0.865 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.859 | |
| regulation of mast cell differentiation | GO:0060375 | 3 | 0.858 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.856 | |
| phospholipase c activating g protein coupled receptor signaling pathway | GO:0007200 | 26 | 0.855 | |
| regulation of response to food | GO:0032095 | 10 | 0.855 | |
| cell adhesion | GO:0007155 | 329 | 0.843 | |
| ovulation from ovarian follicle | GO:0001542 | 9 | 0.842 | |
| positive regulation of fatty acid metabolic process | GO:0045923 | 8 | 0.842 | |
| vasoconstriction | GO:0042310 | 27 | 0.836 | |
| dna metabolic process | GO:0006259 | 303 | 0.831 | |
| regulation of lipid storage | GO:0010883 | 20 | 0.831 | |
| adenylate cyclase modulating g protein coupled receptor signaling pathway | GO:0007188 | 54 | 0.827 | |
| insulin receptor signaling pathway | GO:0008286 | 49 | 0.819 | |
| keratinocyte migration | GO:0051546 | 3 | 0.816 | |
| peptide secretion | GO:0002790 | 114 | 0.799 | |
| exogenous drug catabolic process | GO:0042738 | 1 | 0.798 | |
| regulation of fatty acid beta oxidation | GO:0031998 | 1 | 0.798 | |
| regulation of peptide transport | GO:0090087 | 91 | 0.796 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.794 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.793 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.792 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.790 | |
| g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger | GO:0007187 | 55 | 0.785 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.783 | |
| negative regulation of cellular carbohydrate metabolic process | GO:0010677 | 19 | 0.783 | |
| amide transport | GO:0042886 | 138 | 0.782 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.777 | |
| developmental maturation | GO:0021700 | 193 | 0.776 | |
| peptide transport | GO:0015833 | 133 | 0.770 | |
| positive regulation of triglyceride catabolic process | GO:0010898 | 3 | 0.770 | |
| circulatory system process | GO:0003013 | 197 | 0.770 | |
| response to corticosterone | GO:0051412 | 1 | 0.767 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.765 | |
| lactation | GO:0007595 | 25 | 0.764 | |
| internal protein amino acid acetylation | GO:0006475 | 42 | 0.761 | |
| lipid localization | GO:0010876 | 126 | 0.761 | |
| long chain fatty acid transport | GO:0015909 | 15 | 0.760 | |
| chromatin modification | GO:0016568 | 187 | 0.758 | |
| lipid transport | GO:0006869 | 98 | 0.758 | |
| dicarboxylic acid metabolic process | GO:0043648 | 18 | 0.757 | |
| associative learning | GO:0008306 | 61 | 0.755 | |
| positive regulation of carbohydrate metabolic process | GO:0045913 | 30 | 0.753 | |
| multicellular organismal response to stress | GO:0033555 | 62 | 0.752 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.749 | |
| glycerolipid catabolic process | GO:0046503 | 16 | 0.745 | |
| amine metabolic process | GO:0009308 | 45 | 0.745 | |
| synaptic transmission | GO:0007268 | 329 | 0.743 | |
| forebrain development | GO:0030900 | 302 | 0.742 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.740 | |
| cellular response to prostaglandin stimulus | GO:0071379 | 2 | 0.738 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.735 | |
| cartilage development | GO:0051216 | 140 | 0.733 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.733 | |
| mammary gland lobule development | GO:0061377 | 22 | 0.733 | |
| negative regulation of triglyceride metabolic process | GO:0090209 | 4 | 0.729 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.729 | |
| branching involved in mammary gland duct morphogenesis | GO:0060444 | 27 | 0.728 | |
| positive regulation of inositol phosphate biosynthetic process | GO:0060732 | 2 | 0.726 | |
| negative regulation of insulin secretion | GO:0046676 | 14 | 0.726 | |
| regulation of circadian rhythm | GO:0042752 | 58 | 0.720 | |
| ribose phosphate biosynthetic process | GO:0046390 | 59 | 0.719 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.716 | |
| transforming growth factor beta receptor signaling pathway | GO:0007179 | 71 | 0.711 | |
| regulation of cell migration | GO:0030334 | 219 | 0.710 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.706 | |
| hormone secretion | GO:0046879 | 128 | 0.706 | |
| negative regulation of peptide secretion | GO:0002792 | 16 | 0.704 | |
| cognition | GO:0050890 | 149 | 0.703 | |
| positive regulation of peptide secretion | GO:0002793 | 33 | 0.697 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.695 | |
| purine nucleotide biosynthetic process | GO:0006164 | 65 | 0.692 | |
| regulation of peptide hormone secretion | GO:0090276 | 75 | 0.692 | |
| ossification | GO:0001503 | 216 | 0.690 | |
| positive regulation of chromosome organization | GO:2001252 | 33 | 0.689 | |
| cholesterol storage | GO:0010878 | 4 | 0.673 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.672 | |
| regulation of reactive oxygen species biosynthetic process | GO:1903426 | 2 | 0.671 | |
| intracellular receptor signaling pathway | GO:0030522 | 74 | 0.666 | |
| long term synaptic potentiation | GO:0060291 | 25 | 0.658 | |
| positive regulation of apoptotic process involved in morphogenesis | GO:1902339 | 4 | 0.653 | |
| insulin secretion | GO:0030073 | 89 | 0.650 | |
| response to ketone | GO:1901654 | 15 | 0.649 | |
| mammary gland epithelium development | GO:0061180 | 65 | 0.647 | |
| positive regulation of camp metabolic process | GO:0030816 | 19 | 0.646 | |
| regulation of sequestering of triglyceride | GO:0010889 | 6 | 0.642 | |
| internal peptidyl lysine acetylation | GO:0018393 | 42 | 0.637 | |
| hormone metabolic process | GO:0042445 | 86 | 0.636 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.635 | |
| positive regulation of glucose metabolic process | GO:0010907 | 21 | 0.635 | |
| peptide hormone secretion | GO:0030072 | 109 | 0.626 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.617 | |
| cellular response to prostaglandin e stimulus | GO:0071380 | 1 | 0.616 | |
| catecholamine metabolic process | GO:0006584 | 30 | 0.615 | |
| regulation of system process | GO:0044057 | 200 | 0.610 | |
| response to steroid hormone | GO:0048545 | 56 | 0.607 | |
| positive regulation of camp mediated signaling | GO:0043950 | 3 | 0.602 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.601 | |
| calcium ion transport | GO:0006816 | 159 | 0.600 | |
| developmental programmed cell death | GO:0010623 | 41 | 0.598 | |
| response to increased oxygen levels | GO:0036296 | 2 | 0.596 | |
| regulation of serotonin uptake | GO:0051611 | 2 | 0.595 | |
| regulation of histone acetylation | GO:0035065 | 19 | 0.593 | |
| regulation of nucleotide biosynthetic process | GO:0030808 | 34 | 0.591 | |
| positive regulation of chromatin modification | GO:1903310 | 28 | 0.589 | |
| cellular response to vitamin | GO:0071295 | 2 | 0.586 | |
| oxidation reduction process | GO:0055114 | 342 | 0.580 | |
| response to dexamethasone | GO:0071548 | 8 | 0.579 | |
| odontogenesis | GO:0042476 | 78 | 0.579 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.576 | |
| defense response to other organism | GO:0098542 | 197 | 0.575 | |
| hexose biosynthetic process | GO:0019319 | 39 | 0.573 | |
| regulation of metal ion transport | GO:0010959 | 106 | 0.573 | |
| regulation of the force of heart contraction | GO:0002026 | 17 | 0.567 | |
| positive regulation of sequence specific dna binding transcription factor activity | GO:0051091 | 68 | 0.566 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.565 | |
| response to food | GO:0032094 | 17 | 0.564 | |
| asymmetric stem cell division | GO:0098722 | 3 | 0.564 | |
| cellular response to bile acid | GO:1903413 | 1 | 0.561 | |
| regulation of triglyceride catabolic process | GO:0010896 | 5 | 0.560 | |
| negative regulation of interferon gamma mediated signaling pathway | GO:0060336 | 1 | 0.559 | |
| positive regulation of glial cell proliferation | GO:0060252 | 4 | 0.559 | |
| vitamin d biosynthetic process | GO:0042368 | 3 | 0.558 | |
| positive regulation of apoptotic signaling pathway | GO:2001235 | 95 | 0.557 | |
| regulation of monooxygenase activity | GO:0032768 | 7 | 0.556 | |
| fatty acid transport | GO:0015908 | 28 | 0.556 | |
| development of secondary male sexual characteristics | GO:0046544 | 3 | 0.555 | |
| mapk cascade | GO:0000165 | 281 | 0.553 | |
| female gonad development | GO:0008585 | 71 | 0.552 | |
| regulation of chromosome organization | GO:0033044 | 83 | 0.544 | |
| regulation of carbohydrate catabolic process | GO:0043470 | 12 | 0.539 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.538 | |
| nuclear transport | GO:0051169 | 139 | 0.537 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.537 | |
| acid secretion | GO:0046717 | 33 | 0.537 | |
| taurine metabolic process | GO:0019530 | 4 | 0.535 | |
| carboxylic acid catabolic process | GO:0046395 | 51 | 0.535 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.531 | |
| negative regulation of cellular response to insulin stimulus | GO:1900077 | 16 | 0.530 | |
| positive regulation of peptide hormone secretion | GO:0090277 | 31 | 0.526 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.521 | |
| lipid particle organization | GO:0034389 | 7 | 0.519 | |
| negative regulation of transforming growth factor beta receptor signaling pathway | GO:0030512 | 26 | 0.517 | |
| g protein coupled receptor signaling pathway involved in heart process | GO:0086103 | 4 | 0.514 | |
| peptidyl lysine acetylation | GO:0018394 | 45 | 0.510 | |
| positive regulation of exit from mitosis | GO:0031536 | 1 | 0.510 | |
| epidermis development | GO:0008544 | 187 | 0.509 | |
| nucleotide biosynthetic process | GO:0009165 | 78 | 0.509 | |
| response to activity | GO:0014823 | 13 | 0.507 | |
| cellular response to vitamin d | GO:0071305 | 2 | 0.494 | |
| cholesterol metabolic process | GO:0008203 | 56 | 0.494 | |
| fat soluble vitamin biosynthetic process | GO:0042362 | 4 | 0.493 | |
| astrocyte fate commitment | GO:0060018 | 4 | 0.493 | |
| cellular glucan metabolic process | GO:0006073 | 32 | 0.492 | |
| camp biosynthetic process | GO:0006171 | 31 | 0.491 | |
| cellular carbohydrate catabolic process | GO:0044275 | 15 | 0.490 | |
| jak stat cascade | GO:0007259 | 42 | 0.482 | |
| protein nitrosylation | GO:0017014 | 4 | 0.481 | |
| reactive nitrogen species metabolic process | GO:2001057 | 0 | 0.481 | |
| positive regulation of intracellular estrogen receptor signaling pathway | GO:0033148 | 4 | 0.481 | |
| response to ammonium ion | GO:0060359 | 21 | 0.480 | |
| cation transport | GO:0006812 | 399 | 0.480 | |
| adenylate cyclase inhibiting g protein coupled receptor signaling pathway | GO:0007193 | 20 | 0.479 | |
| regulation of leukocyte apoptotic process | GO:2000106 | 56 | 0.478 | |
| leukocyte apoptotic process | GO:0071887 | 71 | 0.476 | |
| histone acetylation | GO:0016573 | 41 | 0.475 | |
| hair follicle development | GO:0001942 | 85 | 0.470 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.468 | |
| negative regulation of secretion by cell | GO:1903531 | 54 | 0.467 | |
| triglyceride mobilization | GO:0006642 | 5 | 0.464 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.464 | |
| second messenger mediated signaling | GO:0019932 | 73 | 0.461 | |
| negative regulation of sequestering of triglyceride | GO:0010891 | 2 | 0.459 | |
| protein localization to organelle | GO:0033365 | 185 | 0.457 | |
| hormone mediated apoptotic signaling pathway | GO:0008628 | 1 | 0.455 | |
| regulation of glycogen metabolic process | GO:0070873 | 13 | 0.453 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.453 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.451 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.451 | |
| regulation of vasoconstriction | GO:0019229 | 14 | 0.450 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.448 | |
| allantoin metabolic process | GO:0000255 | 3 | 0.448 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.447 | |
| locomotory behavior | GO:0007626 | 195 | 0.445 | |
| glucose import | GO:0046323 | 32 | 0.443 | |
| phenol containing compound biosynthetic process | GO:0046189 | 21 | 0.441 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.441 | |
| regulation of exit from mitosis | GO:0007096 | 1 | 0.441 | |
| negative regulation of carbohydrate metabolic process | GO:0045912 | 19 | 0.440 | |
| citrate metabolic process | GO:0006101 | 3 | 0.440 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.439 | |
| male anatomical structure morphogenesis | GO:0090598 | 4 | 0.438 | |
| trophectodermal cell proliferation | GO:0001834 | 2 | 0.438 | |
| mammary gland branching involved in pregnancy | GO:0060745 | 6 | 0.436 | |
| cell proliferation in hindbrain | GO:0021534 | 10 | 0.433 | |
| bone development | GO:0060348 | 120 | 0.431 | |
| response to pain | GO:0048265 | 26 | 0.430 | |
| response to ethanol | GO:0045471 | 18 | 0.430 | |
| negative regulation of reactive oxygen species biosynthetic process | GO:1903427 | 0 | 0.427 | |
| energy reserve metabolic process | GO:0006112 | 39 | 0.423 | |
| polysaccharide metabolic process | GO:0005976 | 39 | 0.421 | |
| regulation of blood vessel size | GO:0050880 | 56 | 0.417 | |
| apoptotic process involved in development | GO:1902742 | 28 | 0.417 | |
| regulation of cell motility | GO:2000145 | 236 | 0.416 | |
| lipid oxidation | GO:0034440 | 29 | 0.415 | |
| ribonucleotide biosynthetic process | GO:0009260 | 59 | 0.412 | |
| positive regulation of histone modification | GO:0031058 | 28 | 0.412 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.412 | |
| antral ovarian follicle growth | GO:0001547 | 5 | 0.409 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.409 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.408 | |
| urogenital system development | GO:0001655 | 261 | 0.408 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.406 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.404 | |
| response to decreased oxygen levels | GO:0036293 | 59 | 0.403 | |
| cellular response to inorganic substance | GO:0071241 | 37 | 0.401 | |
| regulation of secretion | GO:0051046 | 274 | 0.399 | |
| regulation of glucocorticoid secretion | GO:2000849 | 5 | 0.398 | |
| response to lithium ion | GO:0010226 | 10 | 0.398 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.391 | |
| regulation of histone modification | GO:0031056 | 56 | 0.389 | |
| glycolytic process | GO:0006096 | 20 | 0.389 | |
| response to amphetamine | GO:0001975 | 16 | 0.388 | |
| histone modification | GO:0016570 | 159 | 0.388 | |
| stem cell development | GO:0048864 | 219 | 0.381 | |
| negative regulation of release of cytochrome c from mitochondria | GO:0090201 | 6 | 0.381 | |
| response to cocaine | GO:0042220 | 14 | 0.376 | |
| neuron migration | GO:0001764 | 122 | 0.375 | |
| regulation of ion transport | GO:0043269 | 215 | 0.374 | |
| regulation of camp mediated signaling | GO:0043949 | 7 | 0.373 | |
| response to hyperoxia | GO:0055093 | 2 | 0.371 | |
| regulation of calcidiol 1 monooxygenase activity | GO:0060558 | 1 | 0.370 | |
| ensheathment of neurons | GO:0007272 | 76 | 0.370 | |
| skeletal system development | GO:0001501 | 356 | 0.368 | |
| positive regulation of insulin secretion | GO:0032024 | 26 | 0.363 | |
| response to metal ion | GO:0010038 | 47 | 0.362 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.361 | |
| positive regulation of mammary gland involution | GO:1903521 | 4 | 0.361 | |
| glycogen metabolic process | GO:0005977 | 32 | 0.360 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.359 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.357 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.356 | |
| response to vitamin a | GO:0033189 | 1 | 0.354 | |
| trophectodermal cellular morphogenesis | GO:0001831 | 3 | 0.354 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.353 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.352 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.352 | |
| maintenance of location | GO:0051235 | 89 | 0.351 | |
| cell growth | GO:0016049 | 130 | 0.350 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.349 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.346 | |
| inflammatory response | GO:0006954 | 244 | 0.346 | |
| hormone mediated signaling pathway | GO:0009755 | 23 | 0.346 | |
| purine containing compound biosynthetic process | GO:0072522 | 70 | 0.345 | |
| multicellular organismal metabolic process | GO:0044236 | 28 | 0.344 | |
| regulation of mammary gland involution | GO:1903519 | 4 | 0.344 | |
| primary ovarian follicle growth | GO:0001545 | 2 | 0.344 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.343 | |
| cellular response to steroid hormone stimulus | GO:0071383 | 33 | 0.342 | |
| regulation of purine nucleotide biosynthetic process | GO:1900371 | 34 | 0.342 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.341 | |
| fear response | GO:0042596 | 33 | 0.340 | |
| triglyceride biosynthetic process | GO:0019432 | 17 | 0.338 | |
| prostate gland growth | GO:0060736 | 13 | 0.338 | |
| regulation of steroid biosynthetic process | GO:0050810 | 26 | 0.338 | |
| bone morphogenesis | GO:0060349 | 78 | 0.337 | |
| cytokine mediated signaling pathway | GO:0019221 | 115 | 0.337 | |
| blood circulation | GO:0008015 | 195 | 0.336 | |
| mammary gland morphogenesis | GO:0060443 | 54 | 0.335 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.335 | |
| learning | GO:0007612 | 98 | 0.333 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.332 | |
| response to monosaccharide | GO:0034284 | 67 | 0.331 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.331 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.329 | |
| energy derivation by oxidation of organic compounds | GO:0015980 | 77 | 0.329 | |
| spinal cord development | GO:0021510 | 81 | 0.327 | |
| regulation of cyclic nucleotide biosynthetic process | GO:0030802 | 31 | 0.325 | |
| ovulation cycle | GO:0042698 | 59 | 0.323 | |
| urea metabolic process | GO:0019627 | 3 | 0.323 | |
| positive regulation of cyclic nucleotide metabolic process | GO:0030801 | 24 | 0.318 | |
| acylglycerol biosynthetic process | GO:0046463 | 18 | 0.318 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.318 | |
| response to phenylpropanoid | GO:0080184 | 22 | 0.318 | |
| diacylglycerol metabolic process | GO:0046339 | 6 | 0.316 | |
| positive regulation of cytosolic calcium ion concentration | GO:0007204 | 65 | 0.314 | |
| cation homeostasis | GO:0055080 | 212 | 0.314 | |
| smooth muscle contraction | GO:0006939 | 44 | 0.308 | |
| eating behavior | GO:0042755 | 15 | 0.307 | |
| sterol metabolic process | GO:0016125 | 58 | 0.304 | |
| corticosterone secretion | GO:0035934 | 3 | 0.303 | |
| response to interferon gamma | GO:0034341 | 34 | 0.303 | |
| regulation of steroid hormone biosynthetic process | GO:0090030 | 4 | 0.301 | |
| digestive tract development | GO:0048565 | 190 | 0.301 | |
| negative regulation of cytokine production | GO:0001818 | 84 | 0.300 | |
| type b pancreatic cell proliferation | GO:0044342 | 10 | 0.299 | |
| regulation of histone deacetylation | GO:0031063 | 12 | 0.298 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.297 | |
| intracellular steroid hormone receptor signaling pathway | GO:0030518 | 29 | 0.297 | |
| temperature homeostasis | GO:0001659 | 26 | 0.295 | |
| cellular response to glucose stimulus | GO:0071333 | 45 | 0.295 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.290 | |
| phosphatidylinositol 3 kinase signaling | GO:0014065 | 36 | 0.288 | |
| response to oxygen levels | GO:0070482 | 62 | 0.288 | |
| cellular response to metal ion | GO:0071248 | 31 | 0.286 | |
| wnt signaling pathway involved in kidney development | GO:0061289 | 2 | 0.285 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.285 | |
| regulation of peptidyl lysine acetylation | GO:2000756 | 22 | 0.284 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.282 | |
| positive regulation of sodium ion transmembrane transport | GO:1902307 | 4 | 0.281 | |
| regulation of multicellular organismal metabolic process | GO:0044246 | 14 | 0.279 | |
| positive regulation of vasoconstriction | GO:0045907 | 4 | 0.278 | |
| steroid hormone mediated signaling pathway | GO:0043401 | 6 | 0.274 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.272 | |
| regulation of osteoblast differentiation | GO:0045667 | 67 | 0.271 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.271 | |
| response to estrogen | GO:0043627 | 24 | 0.269 | |
| regulation of stem cell proliferation | GO:0072091 | 78 | 0.268 | |
| regulation of transmembrane transport | GO:0034762 | 128 | 0.268 | |
| positive regulation of sodium ion transport | GO:0010765 | 13 | 0.266 | |
| intestinal absorption | GO:0050892 | 13 | 0.265 | |
| positive regulation of cellular response to insulin stimulus | GO:1900078 | 9 | 0.265 | |
| hair cycle | GO:0042633 | 90 | 0.265 | |
| response to drug | GO:0042493 | 75 | 0.263 | |
| regulation of phosphatidylinositol 3 kinase signaling | GO:0014066 | 30 | 0.263 | |
| prostate epithelial cord elongation | GO:0060523 | 3 | 0.260 | |
| negative regulation of muscle adaptation | GO:0014745 | 2 | 0.260 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.259 | |
| carbohydrate catabolic process | GO:0016052 | 32 | 0.258 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.257 | |
| regulation of saliva secretion | GO:0046877 | 2 | 0.256 | |
| renal system development | GO:0072001 | 225 | 0.256 | |
| peptidyl cysteine modification | GO:0018198 | 8 | 0.255 | |
| positive regulation of behavior | GO:0048520 | 40 | 0.255 | |
| cytosolic calcium ion homeostasis | GO:0051480 | 70 | 0.254 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.253 | |
| organic hydroxy compound biosynthetic process | GO:1901617 | 77 | 0.253 | |
| platelet derived growth factor receptor signaling pathway | GO:0048008 | 32 | 0.253 | |
| response to low density lipoprotein particle | GO:0055098 | 2 | 0.250 | |
| catecholamine uptake involved in synaptic transmission | GO:0051934 | 4 | 0.249 | |
| cell cell signaling involved in metanephros development | GO:0072204 | 2 | 0.248 | |
| hemangioblast cell differentiation | GO:0060217 | 1 | 0.247 | |
| negative regulation of execution phase of apoptosis | GO:1900118 | 4 | 0.242 | |
| multicellular organismal macromolecule metabolic process | GO:0044259 | 19 | 0.242 | |
| response to morphine | GO:0043278 | 9 | 0.242 | |
| regulation of sodium ion transport | GO:0002028 | 29 | 0.242 | |
| purine ribonucleotide biosynthetic process | GO:0009152 | 59 | 0.241 | |
| negative regulation of kinase activity | GO:0033673 | 81 | 0.241 | |
| visceral serous pericardium development | GO:0061032 | 2 | 0.239 | |
| positive regulation of hormone secretion | GO:0046887 | 38 | 0.239 | |
| tissue remodeling | GO:0048771 | 102 | 0.239 | |
| guanosine containing compound metabolic process | GO:1901068 | 144 | 0.238 | |
| response to inorganic substance | GO:0010035 | 96 | 0.238 | |
| positive regulation of erk1 and erk2 cascade | GO:0070374 | 47 | 0.236 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.236 | |
| negative regulation of neurotransmitter uptake | GO:0051581 | 2 | 0.234 | |
| calcium ion transport into cytosol | GO:0060402 | 48 | 0.234 | |
| regulation of calcium ion transport | GO:0051924 | 69 | 0.233 | |
| body fluid secretion | GO:0007589 | 53 | 0.233 | |
| lateral line system development | GO:0048925 | 1 | 0.232 | |
| regulation of myeloid cell differentiation | GO:0045637 | 96 | 0.232 | |
| response to estradiol | GO:0032355 | 12 | 0.231 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.229 | |
| regulation of neuron death | GO:1901214 | 134 | 0.229 | |
| regulation of lymphocyte proliferation | GO:0050670 | 117 | 0.228 | |
| arginine metabolic process | GO:0006525 | 2 | 0.226 | |
| regulation of adrenergic receptor signaling pathway | GO:0071877 | 4 | 0.225 | |
